Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Ceftolozaan-tazobactam versus meropenem bij nosocomiale pneumonie
feb 2020 | Bacteriële infecties, Pneumonie